Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • JBKri
    Member
    • Jan 2014
    • 80

    #1

    Too little PhiX - problem with denaturation?

    Hi all,
    first the TLDR:
    Do you know of any factors that might cause PhiX denaturation to fail or reverse, outside of typical mistakes (NaOH concentration/pipetting mistakes/age)?

    We have performed nearly one hundred MiSeq runs to date in our lab, and mostly they perform as expected. However, in some recent amplicon runs we have seen far less PhiX align than expected based on the % added, e.g. 1-2% aligned rather than 20% expected. This has happened both with an old and a fresh stock of PhiX. It cannot be explained by wrong library quantification, as the cluster densities were approximately as expected from the loading concentration. I quantified the new PhiX stock by qPCR, and it is very close to 10 nM. Also I verfied the insert size from what little did align. I checked the pH of the NaOH stock and dilution (made fresh every time) and it is OK. We have also done a system check of the instrument (optics alignment, volume test, thermal test) and everything passed.

    This leads me to believe something sometimes goes wrong with the denaturation of the PhiX. Once we had some old 12.5 pM aliquots of denatured PhiX (several months at -20), and we saw that the % aligned gradually declined, as expected for old aliquots. But when I made fresh aliquots from the stock it got much worse; almost nothing aligned. At the time I though the stock had gone bad. But then the same thing happened to a completely new stock. I am at a loss to understand why this is happening. I did contact Illumina about this problem and other amplicon run problems we had and got some help, but nothing specifically about the PhiX problem.
    Jon

    Hellenic Centre for Marine Research

Latest Articles

Collapse

  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM
  • SEQadmin2
    New Genomics Technologies Take Aim at Long-Standing Limits
    by SEQadmin2


    Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

    We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
    ...
    09-28-2026, 10:25 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-15-2026, 10:52 AM
0 responses
14 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-14-2026, 05:39 AM
0 responses
21 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-13-2026, 09:56 AM
0 responses
20 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-09-2026, 11:14 AM
0 responses
27 views
0 reactions
Last Post SEQadmin2  
Working...